Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Cytokine"
DOI: 10.1016/j.cyto.2018.05.017
Abstract: HighlightsSerum sCD163 levels correlated positively with the disease activity of s‐JIA, even in patients receiving tocilizumab.Serum sCD163 level is a potential diagnostic laboratory criterion for clinical remission in patients with s‐JIA.Serum sCD163 levels profoundly increased… read more here.
Keywords: scd163; jia; disease activity; scd163 levels ... See more keywords
Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2020.00148
Abstract: Objective: Intravenous immunoglobulin (IVIG) therapy is a useful first-line treatment for Kawasaki disease (KD); however, 10–20% of patients fail to respond and require additional IVIG. Soluble CD163 (sCD163) is considered a biomarker for macrophage activation.… read more here.
Keywords: clinical management; serum scd163; group; ivig ... See more keywords